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1. Introduction 
Cutaneous melanoma is a relatively common skin tumor in the dog, accounting for 5 to 7% 
of canine skin tumors (Bostock, 1986; Rothwell et al., 1987). This tumor originates from the 
transformation of the melanocytes, which are present mainly in the epidermis and hair 
follicles. The transformed melanocytes lose their normal contact with surrounding 
keratinocytes and tend to proliferate to surrounding tissues (Smith et al 2002). Breed has 
been reported to be prognostically significant; more than 75% of melanomas in Doberman 
pinschers and miniature schnauzers are behaviorally benign, whereas 85% of melanomas in 
miniature poodles are malignant (Bolon et al., 1990). 
Cutaneous melanoma can be behaviorally benign or malignant, and can occur anywhere on 
the body. Some investigations into the molecular and genetic basis of melanoma were 
previously performed (Table 1), but the etiology of melanoma is largely unknown. These 
tumors usually can be diagnosed by simple fineneedle aspiration cytology; however, 
histologic examination is important to determine the potential for malignancy (Aronsohn & 
Carpenter 1990; Bolon et al., 1990). 
The therapeutic treatment for local cutaneous melanoma in the dog is surgical excision. It 
shows an excellent prognosis after surgical excision of benign tumors, whereas the 
prognosis of tumors with malignant criteria is guarded or poor; metastatic rates of 30 to 
75% have been reported after the surgery (Withrow & Vail 2007). Systemic chemotherapy 
for malignant melanoma has shown little promise. Some agents, including mitoxantrone 
(Ogilvie et al., 1991), doxorubicin (Moore, 1993), dacarbazine (Gillick & Spiegle, 1987), and 
carboplatin (Rassnick et al., 2001) have been used for treatment. However, in general, the 
effects of these drugs have been poor and the durations of the effects have been 
shortlived. A few researches have been conducted to develop effective therapeutic targets 
in the mechanism of melanoma progression and/or metastasis; however, there is no 
effective strategy until the present time (von Euler et al., 2008; Han et al., 2010; Thamm et 
al., 2010). 
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Factor Normal function Abnormality Reference 
p53 gene 
: activate DNA repair protein 
: hold the cell cycle at the G1/S 
phase 
: initiate apoptosis if the DNA 
damage proves to 
be irreversible 
: exclusion of p53 from the 
nucleus 
Koenig et al., 
2002 
Metallothionein 
: capture harmful oxidant 
radicals 
: inactivates p53 functions 
Dincer et al., 
2001 
RB1 gene 
: hold the cell cycle at the G1/S 
phase 
: exclusion of RB1 from the 
nucleus 
Koenig et al., 
2002 
P16/P21/P27 
: inhibits the activity of CDK2 
and CDK4 
: loss or reduction of ink4a 
gene 
Koenig et al., 
2002 
PTEN gene 
: inhibits the AKT signaling 
pathway 
: loss or reduction of PTEN 
expression 
Koenig et al., 
2002 
NRAS 
: a member of the RAS signal 
transduction 
: mutation of NRAS gene 
Mayr et al., 
2003 
VEGF 
: important signaling protein in 
vasculogenesis 
and angiogenesis 
: improves the angiogenesis 
in tumors 
Rawlings et 
al., 
2003 
Table 1. Cutaneous melanomarelated molecular and genetic factors in dogs. 
2. Wnt/βcatenin signaling pathway 
2.1 Normal regulation of the Wnt/ βcatenin signaling pathway 
2.1.1 Wnt signaling: ligands and receptors 
The Wnt genes encode a group of 19 secreted cysteine rich glycoproteins that act as ligands 
to activate receptormediated signaling pathways that control cell differentiation, cell 
proliferation, and cell motility (Chlen & Moon, 2007). Wnt proteins are defined by sequence 
rather than by functional properties. Because it is difficult to solubilize active Wnt 
molecules, the purification of Wnts is complicated. Its insoluble nature is caused by the lipid 
modification causing hydrophobic state. For example, murine Wnt3a, the first identified 
Wnt protein, undergoes two kinds of lipid modification; first is the addition of palmitate to 
cysteine 77 causing diminishing the ability to activate βcatenin signaling and second is the 
addition of palmitoleoyl to serine 209 causing Wnt3a accumulation in the endoplasmic 
reticulum (Willert et al., 2003; Takada et al., 2006; Galli et al., 2007; Komekado et al., 2007). 
Until now, 
 Wingless (Wg) is the most investigated Wnt molecule . Those 
researches indicate that the hydrophobicity and membrane localization of Wg are lost when 
Porcupine (Porc) gene is eliminated (Zhai et al., 2004; Takeda et al., 2006; Hausmann et al., 
2007). Porc encodes a transmembrane ER protein responsible for Wg lipid modification. 
Consequently, it suggests that Porc is a important mediator of both lipid modification and 
membrane targeting of Wg. 
In Vertebrates, there are two kinds of Wnt signaling pathway; βcatenindependent 
(canonical) and βcateninindependent (noncanonical) signaling pathways. Canonical or β
catenindependent signaling pathway is also called as the Wnt/βcatenin signaling 
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pathway. Two distinct receptor families are important for the Wnt/βcatenin signaling 
pathway: the Frizzled (Fz) seven transmembrane receptors and the LDL receptorrelated 
proteins 5 and 6 (LRP5 and LRP6) (He et al., 2004; Logan and Nusse, 2004). In Wnt/Fz 
interaction, Wnt proteins bind directly to the cysteinerich domain of Fz receptor; however, 
without a cognate ligand, the complex of Wnt/Fz cannot activate Wnt signaling, indicating 
Fz activation is ligand dependent. For participating to Wnt signaling, LRPs need to 
transport to the cell surface by a specific molecule called Boca in 
 or Mesd in mice 
(Culi & Mann, 2003; Hsieh et al., 2003). Two LRPs act different functions at different 
developmental process; LRP6 is more important for embryogenesis while LRP5 is critical for 
adult bone homeostasis. In most data, Wnt induces the formation of FzLRP5/6 complex to 
activate Wnt signaling pathway. 
2.1.2 Wnt signaling: off state 
Cytoplasmic βcatenin phosphorylation and degradation is the characteristic feature (Fig. 1). 
The Axin protein coordinates sequential phosphorylation of βcatenin at serine 45 by CK 1α 
and then threonine 41, serine 37 and serine 33 by glycogen synthase kinase3β (GSK3β) 
through the interaction with separate domains of Axin (Kimelman & Xu, 2006). After then, 
the E3 ubiquitin ligase βTrcp binds to serine 33 and 37 of βcatenin, and leads to βcatenin 
ubiquitination and degradation. GSK3 and CK1 also phosphorylate Axin and Adenomatous 
polyposis coli (APC), resulting in the enhancement of βcatenin phosphorylation and 
degradation through increased association between Axin/APC and βcatenin (Kimelman & 
Xu, 2006; Huang & He, 2008). Additional aspects on Axin complex deserve further 
discussion. 
1. Serine/threonine phosphatases, PP1 and PP2A, counteract the role of GSK3 and/or 
CK1 in the Axin complex. PP1 promote the dissociation of the Axin complex through 
the dephosphorylation of Axin while PP2A dephosphorylates βcatenin. Both reactions 
result in reduced βcatenin degradation (Luo et al., 2007; Su et al., 2008). 
2. Axin concentration is different among each component in  , indicating that Axin 
controls the rate of the complex assembly (Lee et al., 2003). However, it is not sure 
whether the different concentration of Axin in each component is universal to other 
organisms. 
APC is a part of the Axin complex causing βcatenin phosphorylation. APC also inhibit the 
dephosphorylation of βcatenin, and thereby enhancing βcatenin degradation (Su et al., 
2008). APC and Axin compete for same βcatenin, and APC also remove phosphorylated β
catenin from Axin for degradation and for making Axin available for another βcatenin 
phosphorylation (Xing et al., 2003; Kimelman & Xu, 2006). APC also promote to remove β
catenin from the nucleus and suppress βcatenin target genes. 
Interestingly, APC can promote Wnt signaling through the acceleration of Axin degradation 
(Lee et al., 2003; Takacs et al., 2008). It depends on the APC amino acid terminal that is not 
involved in βcatenin degradation. Conversly, Axin can also promote APC degradation 
(Choi et al., 2004). However, the mechanisms of both APC and Axin degradation are not 
known. 
2.1.3 Wnt signaling: on state 
Wnt/βcatenin signaling pathway is important in many developmental processes including 
the formation of neural crestderived melanocytes (Larue & Delmas 2006). In neuralcrest  
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Fig. 1. Regulation of Wnt/βcatenin signaling pathway. In the absence of Wnt signals, the 
cellular concentration of free βcatenin is low, because a complex of the adenomatous 
polyposis coli (APC), glycogen synthase kinase 3β (GSK3β) and axin protein is responsible 
for regulating the level of βcatenin, via GSK3βmediated phosphorylation of specific serin 
and threonine residues in βcatenin. 
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emigration and expansion during the embryogenesis, this pathway has been implicated in 
the migration and differentiation of the melanoblast by βcatenin dependent manner (Fig. 2) 
(Dunn 	  2000; Ikeya 	  1997). A hallmark of the activation of the pathway is the 
accumulation of βcatenin protein in the cytoplasm. Wnt signals influence the proteins that 
regulate βcatenin stability through several mechanisms and thereby induce the activation 
of Wnt target gene through the nuclear translocation of βcatenin as follows; 
1. After the signaling of Wnt proteins, the receptor complex transduces a signal to several 
intracellular proteins that include Dishevelled (Dsh) through a direct binding between 
Dsh and Fz. Dsh is a ubiquitously expressed cytoplasmic protein and interacts with a C
terminal cytoplasmic LysThrXXXTrp motif of Fz (Umbhauer et al., 2000). During the 
process, Dsh is also phosphorylated by several protein kinases such as Par1 (Yanagawa 
et al., 1995; Sun et al., 2001). Wntinduced LRP phosphorylation is also important for the 
receptor activation. LRP5 and LRP6 have five repetitive ProProPro(SerTrp)Pro 
[PPP(S/T)P] motifs, which are involved in constitutive βcatenin signaling (Tamai et al., 
2004; MacDonald et al., 2008). GSK3 and CK1 are responsible for PPP(S/T)P 
phosphorylation after the stimulation of Wnt proteins (Davidson et al., 2005; Zeng et al., 
2005). These dual phosphorylated motifs become a binding site for the Axin complex 
and recruit Axin to LRP6 under Wnt stimulation. Zeng et al. (2008) indicates that GSK3 
is responsible for most PPP(S/T)P phosphorylation in GSK α/β null cell lines. 
Consequently, Axin/GSK3 interaction mediates LRP6 phosphorylation, resulting in the 
accumulation of βcatenin in the cytoplasm. 
2. As described above, the receptors transduce a signal to several intracellular proteins 
that include Dishevelled (Dsh). Activated Dsh acts as a suppressor of the proteasome
mediated degradation, which is controlled by a complex of glycogen synthase kinase3β 
(GSK3β), Axin, Adenomatous polyposis coli (APC), and βTrCP. In particular, Wnt 
signals promote to detach Axin from the complex and thereby, induce βcatenin 
stabilization (Cliffe et al., 2003; Tamai et al., 2004). Consequently, stabilized βcatenin 
accumulates in the cytoplasm. 
3. In vertebrates, Caprin2, a cytoplasmic protein, binds to LRP6 and promotes its 
phosphorylation by GSK3 (Ding et al., 2008). In addition, Caprin2 promotes the 
formation of LRP6AxinGSK3 complex. 
4. Microtubule actin crosslinking factor 1 (Macf1) is a member of the protein that links the 
cytoskeleton to junctional proteins. It seems that this protein is a transporter of Axin to 
LRP6. Its function may be vertebratespecific (Chen et al., 2006). 
5. Cytoplasmic βcatenin can enter and retain in the nucleus (Henderson & Fagotto, 2002; 
Stadeli et al., 2006). Though the mechanism of the movement is not well understand, 
Henderson and Fagotto (2002) suggests that nuclear pore protein interacts directly with 
βcatenin, resulting in the movement to the nucleus. A recent study indicates that JNK2 
and Rac1 constitute a cytoplasmic complex with βcatenin and thereby promote its 
nuclear translocation (Wu et al., 2008). 
6. In the nucleus, βcatenin interacts with transcription factors such as lymphoid 
enhancerbinding factor 1/T cellspecific transcription factor (LEF/TCF) DNAbinding 
proteins. In the absence of Wnt signal, TCF acts as a repressor of Wnt target genes, 
however, βcatenin convert the TCF repressor into a transcriptional activator complex 
and thereby activates the transcription of the target genes including cmyc and cyclin 
D1 that cause a cell proliferation and differentiation. The target genes of Wnt/βcatenin 
signaling pathway are summarized in Table 2. 
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Fig. 2. Regulation of Wnt/βcatenin signaling pathway. Upon Wnt signaling, the activity of 
GSK3β is inhibited by Dsh, hence βcatenin is accumulated in the cytoplasm. The 
accumulated βcatenin can enter the nucleus and activates the target genes such as !"#$%, c
myc and cyclin D1. 
 
Target gene 
Changes in target 
gene expression 
Mediator Reference 
Fz Suppress Wnt Muller et al., 1999 
Dfz2 Suppress Wnt Cadigan et al., 1998 
Dfz3 Activate Wnt Sato et al., 1999 
Fz7  Wnt Willert et al., 2002 
LRP Suppress Wnt Wehrli et al., 2000 
Axin2 Suppress βcatenin Jho et al., 2002 
βTCRP Suppress βcatenin Spiegelman et al., 2000 
TCF1 Suppress TCF Roose et al., 2001 
LEF1 Activate βcatenin Hovanes et al., 2001 
Table 2. The target genes of Wnt/βcatenin signaling pathway. 
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2.2 Dysregulation of the Wnt/ βcatenin signaling pathway 
2.2.1 Wnt signaling in human diseases 
In human medicine, mutations of the Wnt/βcatenin signaling pathway have been 
introduced as a cause of many hereditary disorders, cancer, and other diseases (Table 3). 
These include mutations in several components of Wnt signaling pathway such as ligands 
and receptors. Also, the loss of Ecadherin or the abruption of cadherincatenin complex by 
MET/RON receptor tyrosine kinases (RTKs) can cause the abnormal accumulation of β
catenin into the cells (DanikovitchMiagkova 	. 2001; Nelson and Nusse 2004). 
 
Gene Function Disease References 
Wnt3 
Ligands 
Tetraamelia 
Niemann et al., 
2004 
Wnt4 
Mullerianduct regression and 
viriliation 
BiasonLauber et 
al., 2004 
Wnt7a Fuhrmann syndrome Woods et al., 2006 
Wnt10a 
Odontoonchyodermal 
hypoplasia 
Adaimy et al., 2007 
LRP5 
Receptor 
Hyperparathyroid tumor 
High bone mass 
Osteoporosispseudoglioma 
FEVR eye vascular defects 
Gong et al., 2001; 
Boyden et al., 2002; 
Little et al., 2002; 
Toomes et al., 2004; 
Bjorklund et al., 
2007 
LRP6 
Early coronary disease and 
osteoporosis 
Mani  et al., 2007 
Axin1 
Facilitates βcatenin 
degradation 
Caudal duplication, cancer 
Satoh et al., 2000; 
Oates et al., 2006 
Axin2  Tooth agenesis, cancer 
Liu et al., 2000; 
Lammi et al., 2004 
APC 
Facilitates βcatenin 
degradation 
Familial adenomatous 
polyposis, cancer 
Kinzler et al., 1991; 
Nishisho et al., 1991 
β
catenin 
Signal transducer Cancer 
Korinek et al., 1997; 
Morin et al., 1997 
TCF 
Transcriptional 
partner of βcatenin 
Type II diabetes (?) 
Florez et al., 2006; 
Grant et al., 2006 
Table 3. Human diseases caused by mutations of the Wnt/βcatenin signaling pathway 
Association of dysregulated Wnt/βcatenin signaling pathway with human cancer has also 
been documented through constitutively activated βcatenin signaling. Dysfunction of 
APC/Axin/GSK3 complex or βcatenin mutation (especially in exon 3) blocks its 
degradation and consequently, accumulated βcatenin leads to excessive cell proliferation 
that predisposes cells to tumorigenesis. Particularly, in human skin melanoma, dysregulated 
Wnt/βcatenin signaling pathway is essential for metastasis. In this tumor, the 
transformation of normal melanocytes into melanoma cells is a multistep process (Albino et 
al., 1991; Haass et al., 2005; Meier et al., 2000; Shih & Herlyn 1993). The first step, considered 
as benign, is associated with the formation of a nevus and the radial growth phase (RGP). 
During RGP, melanocytes tend to proliferate superficially to the basement membrane of the 
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epidermis. During the next stage, the vertical growth phase (VGP), the cells bypass 
senescence to proliferate actively in a vertical manner in the dermis, crossing the basement 
membrane. At this stage, the cells migrate and become clearly invasive (Fig. 3). In RGP and 
VGP, the alteration of Wnt/βcatenin signaling pathway has been considered to act 
fundamental roles (Sanders et al. 1999; Larue and Beermann 2007). However, in human, 
only infrequent mutation has been found in genes encoding the components, such as APC 
and βcatenin. Therefore, it is presumed that Wnt/βcatenin signaling is probably activated 
by changes in the expression of genes encoding the components directly involved in the 
signaling pathway or associated with the regulation of this pathway (Larue and Delmas 
2006). 
 
 
Fig. 3. Cutaneous melanomagenesis in human. After the formation of nervi, constitutively 
activated βcatenin results in the progress of RGP and VGP, inducing tumor cell metastasis. 
BM, basement membrane.  
2.2.2 Wnt signaling in canine diseases 
In dogs, abnormalities of the Wnt/βcatenin signaling pathway have been investigated in 
mammary tumor and skin melanoma (Gama et al., 2008; Han et al., 2010). In both studies, 
decreased membrane βcatenin expression was consistently observed, indicating the 
disruption of intercellular adhesion (Fig. 4). On plasma membrane level, βcatenin acts as a 
bridge that links cadherin to the cytoskeleton in the plasma membrane of the normal cell 
(Demunter et al. 2002; Sanders et al. 1999). Thus, the loss of cadherin molecule or the 
disruption of cadherincatenin complex can induce the release of βcatenin into the 
cytoplasm. The loss of Ecadherin and the activated MET/RON receptor tyrosine kinases 
(RTKs) have been reported to cause the cytoplasmic release of βcatenin in human 
melanoma and normal canine kidney cells (DanilkovitchMiagkova et al. 2001; Demunter et 
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al. 2002; Sanders et al. 1999). In the study of canine skin melanoma, the authors observed 
significantly increased βcatenin expression in mRNA level (Han et al., 2010). It seems that 
the increased synthesis of βcatenin can also induce the cytoplasmic accumulation, besides 
the translocation of membrane βcatenin. Wnt factor has been considered to increase the 
synthesis of βcatenin in human (DanilkovitchMiagkova et al. 2001; Larue and Delmas 
2006). However, the expression level of βcatenin in protein level is needed to confirm our 
hypothesis as increased RNA synthesis does not always equate with increased protein 
synthesis. The authors also examined consistently decreased expression of membrane E
cadherin in all canine skin melanoma tissues, indicating the disruption of intercellular 
adhesion (Fig. 5, unpublished). However, the authors couldn’t conclude the relationship 
between Ecadherin and βcatenin because of low sample number. In another study, the 
authors observed that only 28% of tumor tissues revealed overexpressed MET/RON RTKs 
indicating that those RTKs were not a major contributing factor for increased βcatenin 
expression in the cytoplasm (Han et al., 2009). As a next study, the authors are examining 
the mutation of βcatenin gene. GSK3/APC/Axin complex recognizes the amino acid 
sequence encoded by exon 3 of βcatenin gene and initiates phosphorylation, followed by 
degradation of βcatenin. 
 
 
Fig. 4. Immunohistochemistry for βcatenin in canine skin melanoma showing variable 
membrane expression and cytoplasmic translocation of βcatenin (authors’ study). 
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Fig. 5. Immunohistochemistry for Ecadherin  in canine skin melanoma showing variable 
membrane expression of Ecadherin (authors’ study). 
3. Spontaneous canine skin melanoma as a model for human melanoma 
Spontaneous tumors in companion animals are suitable models for human cancer. They 
share a similar lifestyle with human (their owner), and have a relatively high incidence of 
tumors, large body size and shorter life span (Vail & MacEwen, 2000). Their tumors are also 
spontaneously occurring and genetically heterogenous in contrast to the tumor of 
experimental animals induced by chemical or transplantation. In companion animals, 
tumors that have a potential to be a model for human are mammary carcinoma, 
osteosarcoma, melanoma, lymphoma and leukemia. 
Although a lot of investigations and therapeutic trials have been conducted, the incidence 
and deaths by skin melanoma continue to increase in human, particularly Caucasian 
population (Longstreet, 1988; Woodhead et al., 1999). In human, melanoma classifies four 
subtypes; superficial spreading melanoma (SSM), nodular melanoma, lentigo maligna 
melanoma and acral lentiginous melanoma. SSM is the most common type of melanoma, 
accounting for about 70% of all diagnosed cases. The most aggressive type is, however, 
nodular melanoma. Nodular melanoma is the second common type, accounting for 15% of 
all diagnosed cases. Usually, it develops in people aged 60 and older. Because of high 
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incidence of the alteration in Wnt/βcatenin signaling pathway, a genetically modified 
mouse model has been developed (Delmas et al. 2007). However, the location of 
melanocytes in mice differs from that in the human skin and a mouse model does not 
spontaneously develop melanoma (Larue and Beermann 2007). Whereas, in normal skin of 
the dog, the melanocyte is mainly present in the basal layer of the epidermis and hair follicle 
similar to that of the human. In addition, the age incidence, histopathology and biological 
behavior, which rapidly progression to vertical growth phase (VGP) without radial growth 
phase (RGP) in canine cutaneous melanoma are very similar to the feature of human 
cutaneous nodular melanoma (Chamberlain et al. 2003; Gross et al. 2005; Smith et al. 2002). 
It suggests that the canine cutaneous melanoma could be a suitable model for therapeutic 
trial by correcting the altered Wnt/βcatenin signaling pathway. 
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